MUTAMYCIN Trademark

Trademark Overview

On Friday, October 16, 2015, a trademark application was filed for MUTAMYCIN with the United States Patent and Trademark Office. The USPTO has given the MUTAMYCIN trademark a serial number of 86790540. The federal status of this trademark filing is REGISTERED as of Tuesday, January 9, 2018. This trademark is owned by Accord Healthcare, Inc.. The MUTAMYCIN trademark is filed in the Pharmaceutical Products category with the following description:

ANTIBIOTIC WITH ANTITUMOR ACTIVITY
mutamycin

General Information

Serial Number86790540
Word MarkMUTAMYCIN
Filing DateFriday, October 16, 2015
Status700 - REGISTERED
Status DateTuesday, January 9, 2018
Registration Number5375762
Registration DateTuesday, January 9, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 27, 2016

Trademark Statements

Goods and ServicesANTIBIOTIC WITH ANTITUMOR ACTIVITY

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 21, 2015
Primary Code005
First Use Anywhere DateWednesday, July 26, 2017
First Use In Commerce DateWednesday, July 26, 2017

Trademark Owner History

Party NameAccord Healthcare, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRaleigh, NC 27617
Party NameAccord Healthcare, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDurham, NC 27703
Party NameAccord Healthcare, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDurham, NC 27703

Trademark Events

Event DateEvent Description
Monday, February 8, 2016NON-FINAL ACTION E-MAILED
Tuesday, October 20, 2015NEW APPLICATION ENTERED
Wednesday, October 21, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 8, 2016ASSIGNED TO EXAMINER
Monday, February 8, 2016NON-FINAL ACTION WRITTEN
Monday, February 8, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 19, 2017SOU TEAS EXTENSION RECEIVED
Thursday, August 4, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 4, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 4, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 12, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 7, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 27, 2016PUBLISHED FOR OPPOSITION
Tuesday, September 27, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 22, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, May 19, 2017SOU EXTENSION 1 FILED
Friday, May 19, 2017SOU EXTENSION 1 GRANTED
Tuesday, January 9, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, May 23, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 31, 2017TEAS STATEMENT OF USE RECEIVED
Tuesday, October 31, 2017USE AMENDMENT FILED
Tuesday, November 14, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 15, 2017STATEMENT OF USE PROCESSING COMPLETE
Monday, December 4, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, December 5, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, May 9, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 9, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, May 9, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, May 9, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, May 9, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 9, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 9, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

mutamycin activity antitumor antibiotic